234 related articles for article (PubMed ID: 17663504)
1. Veno occlusive disease: update on clinical management.
Senzolo M; Germani G; Cholongitas E; Burra P; Burroughs AK
World J Gastroenterol; 2007 Aug; 13(29):3918-24. PubMed ID: 17663504
[TBL] [Abstract][Full Text] [Related]
2. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
3. Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
Gómez-Centurión I; Bailén R; Oarbeascoa G; Muñoz C; Luque AÁ; Boyra ME; Calleja E; Rincón D; Dorado N; Barzallo P; Anguita J; Díez-Martín JL; Kwon M
Biol Blood Marrow Transplant; 2020 Nov; 26(11):2089-2097. PubMed ID: 32791193
[TBL] [Abstract][Full Text] [Related]
4. Use of defibrotide in the treatment and prevention of veno-occlusive disease.
Richardson P; Linden E; Revta C; Ho V
Expert Rev Hematol; 2009 Aug; 2(4):365-76. PubMed ID: 21082942
[TBL] [Abstract][Full Text] [Related]
5. Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report.
Lee TB; Yang K; Ko HJ; Shim JR; Choi BH; Lee JH; Ryu JH
Medicine (Baltimore); 2021 Jun; 100(25):e26463. PubMed ID: 34160449
[TBL] [Abstract][Full Text] [Related]
6. Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
Corbacioglu S; Kernan N; Lehmann L; Brochstein J; Revta C; Grupp S; Martin P; Richardson PG
Expert Rev Hematol; 2012 Jun; 5(3):291-302. PubMed ID: 22780209
[TBL] [Abstract][Full Text] [Related]
7. [Veno-occlusive disease--an important complication in hematopoietic cells transplantation].
Skotnicki AB; Krawczyk J
Przegl Lek; 2001; 58(11):995-9. PubMed ID: 11987843
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcome of Veno-Occlusive Disease After Liver Transplant: A Retrospective Single-Center Experience.
Patrono D; Marola S; David E; Chiusa L; Martini S; Mirabella S; Lupo F; Salizzoni M; Romagnoli R
Exp Clin Transplant; 2019 Apr; 17(2):214-221. PubMed ID: 30381049
[TBL] [Abstract][Full Text] [Related]
9. Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation.
Cheuk DK; Chiang AK; Ha SY; Chan GC
Cochrane Database Syst Rev; 2015 May; 2015(5):CD009311. PubMed ID: 26017019
[TBL] [Abstract][Full Text] [Related]
10. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
[TBL] [Abstract][Full Text] [Related]
11. Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome.
Richardson PG; Murakami C; Jin Z; Warren D; Momtaz P; Hoppensteadt D; Elias AD; Antin JH; Soiffer R; Spitzer T; Avigan D; Bearman SI; Martin PL; Kurtzberg J; Vredenburgh J; Chen AR; Arai S; Vogelsang G; McDonald GB; Guinan EC
Blood; 2002 Dec; 100(13):4337-43. PubMed ID: 12393437
[TBL] [Abstract][Full Text] [Related]
12. Veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East/North Africa regional consensus on prevention, diagnosis and management.
Al Jefri AH; Abujazar H; Al-Ahmari A; Al Rawas A; Al Zahrani Z; Alhejazi A; Bekadja MA; Ibrahim A; Lahoucine M; Ousia S; Bazarbachi A
Bone Marrow Transplant; 2017 Apr; 52(4):588-591. PubMed ID: 27892944
[TBL] [Abstract][Full Text] [Related]
13. Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children.
Qureshi A; Marshall L; Lancaster D
Pediatr Blood Cancer; 2008 Apr; 50(4):831-2. PubMed ID: 18286502
[TBL] [Abstract][Full Text] [Related]
14. Hepatic veno-occlusive disease after bone marrow transplant.
Carreras E; Grañena A; Rozman C
Blood Rev; 1993 Mar; 7(1):43-51. PubMed ID: 8467232
[TBL] [Abstract][Full Text] [Related]
15. Veno-occlusive disease of the liver after hemopoietic cell transplantation.
Carreras E
Eur J Haematol; 2000 May; 64(5):281-91. PubMed ID: 10863974
[TBL] [Abstract][Full Text] [Related]
16. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ
Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784
[TBL] [Abstract][Full Text] [Related]
17. Defibrotide: a review of its use in severe hepatic veno-occlusive disease following haematopoietic stem cell transplantation.
Keating GM
Clin Drug Investig; 2014 Dec; 34(12):895-904. PubMed ID: 25351934
[TBL] [Abstract][Full Text] [Related]
18. The use of defibrotide in blood and marrow transplantation.
Richardson PG; Carreras E; Iacobelli M; Nejadnik B
Blood Adv; 2018 Jun; 2(12):1495-1509. PubMed ID: 29945939
[TBL] [Abstract][Full Text] [Related]
19. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.
Ho VT; Revta C; Richardson PG
Bone Marrow Transplant; 2008 Feb; 41(3):229-37. PubMed ID: 17994121
[TBL] [Abstract][Full Text] [Related]
20. Transjugular intrahepatic portosystemic shunting (TIPS) for treatment of severe hepatic veno-occlusive disease.
Smith FO; Johnson MS; Scherer LR; Faught P; Breitfeld PP; Albright E; Hillier SC; Gowan D; Smith PD; Robertson KA; Emanuel D
Bone Marrow Transplant; 1996 Sep; 18(3):643-6. PubMed ID: 8879632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]